50 related articles for article (PubMed ID: 19100123)
1. [Transgenic models of dilated cardiomyopathy].
Bai YN; Hu K; Ge JB
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Aug; 36(8):755-8. PubMed ID: 19100123
[No Abstract] [Full Text] [Related]
2. Gene therapy for cardiovascular disorders.
Indolfi C; Chiariello M
Cardiologia; 1998 Apr; 43(4):365-73. PubMed ID: 9659794
[No Abstract] [Full Text] [Related]
3. NO and PGI(2) in coronary endothelial dysfunction in transgenic mice with dilated cardiomyopathy.
Drelicharz L; Kozlovski V; Skorka T; Heinze-Paluchowska S; Jasinski A; Gebska A; Guzik T; Olszanecki R; Wojnar L; Mende U; Csanyi G; Chlopicki S
Basic Res Cardiol; 2008 Sep; 103(5):417-30. PubMed ID: 18431525
[TBL] [Abstract][Full Text] [Related]
4. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
[TBL] [Abstract][Full Text] [Related]
5. A matter of life and death: cardiac myocyte apoptosis and regeneration.
Nadal-Ginard B; Kajstura J; Anversa P; Leri A
J Clin Invest; 2003 May; 111(10):1457-9. PubMed ID: 12750394
[No Abstract] [Full Text] [Related]
6. Late-stage alterations in myofibrillar contractile function in a transgenic mouse model of dilated cardiomyopathy (Tgalphaq*44).
Edes IF; Tóth A; Csányi G; Lomnicka M; Chłopicki S; Edes I; Papp Z
J Mol Cell Cardiol; 2008 Sep; 45(3):363-72. PubMed ID: 18674539
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of type 2 iodothyronine deiodinase in dilated cardiomyopathy.
Wang YY; Morimoto S; Du CK; Lu QW; Zhan DY; Tsutsumi T; Ide T; Miwa Y; Takahashi-Yanaga F; Sasaguri T
Cardiovasc Res; 2010 Sep; 87(4):636-46. PubMed ID: 20453157
[TBL] [Abstract][Full Text] [Related]
8. Improved cardiac tagging resolution at ultra-high magnetic field elucidates transmural differences in principal strain in the mouse heart and reduced stretch in dilated cardiomyopathy.
Hankiewicz JH; Lewandowski ED
J Cardiovasc Magn Reson; 2007; 9(6):883-90. PubMed ID: 18066748
[TBL] [Abstract][Full Text] [Related]
9. Altered cAMP-mediated signalling and its role in the pathogenesis of dilated cardiomyopathy.
Movsesian MA
Cardiovasc Res; 2004 Jun; 62(3):450-9. PubMed ID: 15158137
[TBL] [Abstract][Full Text] [Related]
10. The changes of the cardiac structure and function in cTnTR141W transgenic mice.
Juan F; Wei D; Xiongzhi Q; Ran D; Chunmei M; Lan H; Chuan Q; Lianfeng Z
Int J Cardiol; 2008 Aug; 128(1):83-90. PubMed ID: 18606313
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin expression in cardiomyocytes induces dilated cardiomyopathy.
Renault MA; Robbesyn F; Réant P; Douin V; Daret D; Allières C; Belloc I; Couffinhal T; Arnal JF; Klingel K; Desgranges C; Dos Santos P; Charpentier F; Gadeau AP
Circ Heart Fail; 2010 May; 3(3):431-9. PubMed ID: 20200330
[TBL] [Abstract][Full Text] [Related]
12. Temporally controlled onset of dilated cardiomyopathy through disruption of the SRF gene in adult heart.
Parlakian A; Charvet C; Escoubet B; Mericskay M; Molkentin JD; Gary-Bobo G; De Windt LJ; Ludosky MA; Paulin D; Daegelen D; Tuil D; Li Z
Circulation; 2005 Nov; 112(19):2930-9. PubMed ID: 16260633
[TBL] [Abstract][Full Text] [Related]
13. Dilated cardiomyopathy is associated with reduced expression of the cardiac sodium channel Scn5a.
Hesse M; Kondo CS; Clark RB; Su L; Allen FL; Geary-Joo CT; Kunnathu S; Severson DL; Nygren A; Giles WR; Cross JC
Cardiovasc Res; 2007 Aug; 75(3):498-509. PubMed ID: 17512504
[TBL] [Abstract][Full Text] [Related]
14. Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy.
Huang WY; Aramburu J; Douglas PS; Izumo S
Nat Med; 2000 May; 6(5):482-3. PubMed ID: 10802676
[No Abstract] [Full Text] [Related]
15. [Dilated cardiomyopathy].
Kel'man IM
Sov Med; 1991; (9):51-3. PubMed ID: 1665925
[No Abstract] [Full Text] [Related]
16. A novel beta-myosin heavy chain gene mutation, p.Met531Arg, identified in isolated left ventricular non-compaction in humans, results in left ventricular hypertrophy that progresses to dilation in a mouse model.
Kaneda T; Naruse C; Kawashima A; Fujino N; Oshima T; Namura M; Nunoda S; Mori S; Konno T; Ino H; Yamagishi M; Asano M
Clin Sci (Lond); 2008 Mar; 114(6):431-40. PubMed ID: 17956225
[TBL] [Abstract][Full Text] [Related]
17. Junctophilin type 2 is associated with caveolin-3 and is down-regulated in the hypertrophic and dilated cardiomyopathies.
Minamisawa S; Oshikawa J; Takeshima H; Hoshijima M; Wang Y; Chien KR; Ishikawa Y; Matsuoka R
Biochem Biophys Res Commun; 2004 Dec; 325(3):852-6. PubMed ID: 15541368
[TBL] [Abstract][Full Text] [Related]
18. Substance P is associated with heart enlargement and apoptosis in murine dilated cardiomyopathy induced by Taenia crassiceps infection.
D'Souza M; Garza MA; Xie M; Weinstock J; Xiang Q; Robinson P
J Parasitol; 2007 Oct; 93(5):1121-7. PubMed ID: 18163347
[TBL] [Abstract][Full Text] [Related]
19. Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression.
Wang J; Wilhelmsson H; Graff C; Li H; Oldfors A; Rustin P; Brüning JC; Kahn CR; Clayton DA; Barsh GS; Thorén P; Larsson NG
Nat Genet; 1999 Jan; 21(1):133-7. PubMed ID: 9916807
[TBL] [Abstract][Full Text] [Related]
20. Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation.
Du CK; Morimoto S; Nishii K; Minakami R; Ohta M; Tadano N; Lu QW; Wang YY; Zhan DY; Mochizuki M; Kita S; Miwa Y; Takahashi-Yanaga F; Iwamoto T; Ohtsuki I; Sasaguri T
Circ Res; 2007 Jul; 101(2):185-94. PubMed ID: 17556660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
